Asker Healthcare Group - Public Comps and Valuation Multiples

Asker Healthcare Group Overview

About Asker Healthcare Group

Asker Healthcare Group AB is a provider of medical products and solutions that drive progress in the European healthcare sector. The company is engaged in building and acquiring companies to support the healthcare system to improve patient outcomes, reduce the total cost of care, and ensure a fair and sustainable value chain. The company also offers a range of value-added solutions to support its suppliers and customers in, for example, market access, efficiency, and sustainability.

Founded

2006

HQ

Employees

4.0K+

Website

asker.com

Sectors

Hospitals & Clinics

Financials

LTM Revenue $1.7B

LTM EBITDA $195M

EV

$3.8B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Asker Healthcare Group Financials

As of September 2025, Asker Healthcare Group reported last 12-month revenue of $1.7B and EBITDA of $195M.

In the same period, Asker Healthcare Group generated $540M in LTM gross profit and $70.6M in net income.

See Asker Healthcare Group valuation multiples based on analyst estimates

Asker Healthcare Group P&L

In the most recent fiscal year, Asker Healthcare Group reported revenue of $1.6B and EBITDA of $155M.

Asker Healthcare Group expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Asker Healthcare Group valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$1.7B	XXX	$1.6B	XXX	XXX	XXX
Gross Profit	$540M	XXX	$618M	XXX	XXX	XXX
Gross Margin	31%	XXX	39%	XXX	XXX	XXX
EBITDA	$195M	XXX	$155M	XXX	XXX	XXX
EBITDA Margin	11%	XXX	10%	XXX	XXX	XXX
EBIT	$139M	XXX	$102M	XXX	XXX	XXX
EBIT Margin	8%	XXX	6%	XXX	XXX	XXX
Net Profit	$70.6M	XXX	$37.9M	XXX	XXX	XXX
Net Margin	4%	XXX	2%	XXX	XXX	XXX
Net Debt	XXX	XXX	$474M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Asker Healthcare Group including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $1.7B. EBITDA for the last twelve months was $195M. In the most recent fiscal year, Asker Healthcare Group achieved $1.6B in revenue and $155M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$1.7B	Analyst estimates available to subscribers	$1.6B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$540M	Analyst estimates available to subscribers	$618M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	30.9% gross margin	Analyst estimates available to subscribers	39.1% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$195M	Analyst estimates available to subscribers	$155M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	11.2% EBITDA margin	Analyst estimates available to subscribers	9.8% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$139M	Analyst estimates available to subscribers	$102M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	7.9% EBIT margin	Analyst estimates available to subscribers	6.5% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$70.6M	Analyst estimates available to subscribers	$37.9M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	4.0% net profit margin	Analyst estimates available to subscribers	2.4% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$474M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Asker Healthcare Group

This financial data table provides comprehensive performance metrics for Asker Healthcare Group, a company based in Sweden. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Asker Healthcare Group generated $1.7B in revenue over the last twelve months.
The company achieved $195M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $540M.
Net income over the last twelve months reached $70.6M.

Fiscal Year Performance

In the most recent fiscal year, Asker Healthcare Group reported $1.6B in total revenue.
Fiscal year EBITDA was $155M.
The company maintained a gross profit margin of 39.1% in the most recent fiscal year.
EBITDA margin for the fiscal year was 9.8%.
Net profit margin reached 2.4% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Asker Healthcare Group. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Asker Healthcare Group Stock Performance

Asker Healthcare Group has current market cap of SEK 32.3B (or $3.4B), and EV of SEK 36.0B (or $3.8B).

Market Cap Evolution

Asker Healthcare Group Stock Data

As of October 17, 2025, Asker Healthcare Group's stock price is SEK 84 (or $9).

See Asker Healthcare Group trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$3.8B	$3.4B	XXX	XXX	XXX	XXX	$0.24

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Asker Healthcare Group Valuation Multiples

Asker Healthcare Group's trades at 2.4x EV/Revenue multiple, and 24.5x EV/EBITDA.

See valuation multiples for Asker Healthcare Group and 15K+ public comps

Asker Healthcare Group Financial Valuation Multiples

As of October 17, 2025, Asker Healthcare Group has market cap of $3.4B and EV of $3.8B.

Equity research analysts estimate Asker Healthcare Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Asker Healthcare Group has a P/E ratio of 48.1x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$3.4B	XXX	$3.4B	XXX	XXX	XXX
EV (current)	$3.8B	XXX	$3.8B	XXX	XXX	XXX
EV/Revenue	2.2x	XXX	2.4x	XXX	XXX	XXX
EV/EBITDA	19.5x	XXX	24.5x	XXX	XXX	XXX
EV/EBIT	27.3x	XXX	37.1x	XXX	XXX	XXX
EV/Gross Profit	7.0x	XXX	n/a	XXX	XXX	XXX
P/E	48.1x	XXX	89.6x	XXX	XXX	XXX
EV/FCF	66.4x	XXX	41.0x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Asker Healthcare Group Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Asker Healthcare Group Margins & Growth Rates

Asker Healthcare Group's last 12 month revenue growth is 10%

Asker Healthcare Group's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.

Asker Healthcare Group's rule of 40 is 18% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Asker Healthcare Group's rule of X is 36% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Asker Healthcare Group and other 15K+ public comps

Asker Healthcare Group Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	10%	XXX	11%	XXX	XXX	XXX
EBITDA Margin	11%	XXX	10%	XXX	XXX	XXX
EBITDA Growth	16%	XXX	31%	XXX	XXX	XXX
Rule of 40	18%	XXX	20%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	36%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.4M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	23%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	33%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial